Yahoo Web Search

Search results

    • MedTech Outlook 2024 for Latin America Released

      Digital Journal· 14 hours ago

      ...Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour...

    • Rekor Discover(TM) Takes Center Stage at NaTMEC 2024

      Digital Journal· 3 days ago

      With our Rekor One® Roadway Intelligence Engine at the core of our technology, we aggregate and transform trillions of data points into intelligence through proprietary computer ...